info@strategicmarketresearch.com
92, An Guha Lane, Arya Samaj Gali, Sambalpur, Odisha -768001
Indian Flag  IN: +91-826-083-6500
Home » healthcare

Healthcare

IgA Nephropathy Market By Therapy Type (Corticosteroid-Sparing Therapies, Endothelin Receptor Antagonists, Complement Inhibitors, Supportive Care); By Route of Administration (Oral, Injectable); By End User (Academic and Tertiary Hospitals, Specialty Nephrology Clinics, Retail and Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2025–2030

Introduction And Strategic Context

The Global IgA Nephropathy Market is set to register steady expansion at a CAGR of 6.5%, growing from USD 3.8 billion in 2024 to USD 5.8 billion by 2030, driven by <... Read More

Published Date: DEC-2025 | No Of Pages:177 | $ 4485

HER2 Positive Gastric Cancer Market By Therapy Type (Monoclonal Antibodies, Antibody-Drug Conjugates, Tyrosine Kinase Inhibitors, Immunotherapies); By Line of Treatment (First-Line, Second-Line, Third-Line & Beyond); By Diagnostic Modality (IHC, FISH, NGS); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Infusion Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global HER2 Positive Gastric Cancer Market will witness a steady CAGR of 6.8% , valued at USD 3.7 billion in 2024 , and projected to reach nearl... Read More

Published Date: DEC-2025 | No Of Pages:182 | $ 4485

Hematopoietic Stem Cells Transplantation Market By Transplant Type (Autologous, Allogeneic); By Source of Stem Cells (Bone Marrow, Peripheral Blood, Umbilical Cord Blood); By Application (Oncology, Hematology, Rare Genetic Disorders); By End User (Academic Hospitals, General Hospitals, Specialty Transplant Centers, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hematopoietic Stem Cells Transplantation (HSCT) Market is set to advance at a healthy CAGR of 8.1%, reaching USD 10.7 billion by 2030 from USD 6.7 billion in 2024<... Read More

Published Date: DEC-2025 | No Of Pages:166 | $ 4485

Gene and Cell Therapies Targeting CNS Disorders Market By Therapy Type (Gene Therapy, Cell Therapy, Gene-Modified Cell Therapy); By Indication (Parkinson’s Disease, ALS, SMA, Huntington’s Disease, Alzheimer’s Disease, Rare Pediatric CNS Disorders); By Delivery Method (Intrathecal, Intravenous, Intraparenchymal, Intranasal); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Gene and Cell Therapies Targeting CNS Disorders Market is set to grow at a compelling CAGR of 18.4% , starting from an e... Read More

Published Date: DEC-2025 | No Of Pages:152 | $ 4485

Fibromyalgia Treatment Market By Drug Class (SNRIs, Anticonvulsants, Tricyclic Antidepressants, Muscle Relaxants, Others); By Route of Administration (Oral, Topical, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Fibromyalgia Treatment Market will grow at a compound annual growth rate of 5.2 %, rising from USD 3.6 billion in 2024 to USD 4.88 billion by 2030, fueled... Read More

Published Date: DEC-2025 | No Of Pages:166 | $ 4485

DiGeorge Syndrome Drug Market By Drug Class (Immunomodulators and Immunoglobulins, Hormone Replacement Therapies, Antipsychotics and Behavioral Medications, Supportive Medications); By Therapeutic Target (Immune System Dysfunction, Endocrine and Metabolic Dysfunction, Neurodevelopmental and Psychiatric Symptoms, Congenital Heart Defects and Surgical Support); By Distribution Channel (Hospital Pharmacies, Specialty Clinics, Retail Pharmacies and Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Digeorge Syndrome Drug Market is projected to grow at a CAGR of 8.1% from 2024 to 2030 , moving from an estimated USD 328Read More

Published Date: DEC-2025 | No Of Pages:175 | $ 4485

Cutaneous Lupus Erythematosus Market By Disease Subtype (Acute CLE, Subacute CLE, Chronic CLE); By Treatment Class (Topical Agents, Antimalarials, Immunosuppressants, Biologics & Small Molecules); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cutaneous Lupus Erythematosus (CLE) Market will witness steady expansion at a CAGR of 6.4%, reaching USD 3.1 billion by 2030 from USD 2.1 billion in 2024,... Read More

Published Date: DEC-2025 | No Of Pages:171 | $ 4485

COMT Inhibitors Market By Drug Type (Entacapone, Tolcapone, Opicapone); By Application (Parkinson’s Disease, Neurological Disorders); By Route of Administration (Oral); By End User (Hospitals, Specialty Clinics, Retail & Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global COMT Inhibitors Market is projected to grow at a steady pace, with a Compound Annual Growth Rate ( CAGR ) Of 6.8% , reac... Read More

Published Date: DEC-2025 | No Of Pages:167 | $ 4485

Chronic Spontaneous Urticaria Treatment Market By Treatment Type (Antihistamines, Biologics, Leukotriene Receptor Antagonists, Corticosteroids, Others); By Route of Administration (Oral, Injectable, Topical); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chronic Spontaneous Urticaria (CSU) Treatment Market is projected to expand steadily between 2024 and 2030, driven by a combination of rising disease prev... Read More

Published Date: DEC-2025 | No Of Pages:174 | $ 4485

Chronic Rhinosinusitis With Nasal Polyps Market By Treatment Type (Corticosteroids, Biologics, Surgery, Others); By Route of Administration (Intranasal, Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chronic Rhinosinusitis With Nasal Polyps Market will expand at a stable CAGR of 6.8%, growing from USD 5.1 billion in 2024 to USD 7.6 billion by 2030, fue... Read More

Published Date: DEC-2025 | No Of Pages:160 | $ 4485

Chronic Obstructive Pulmonary Disease (COPD) Treatment Market By Drug Class (Bronchodilators, Corticosteroids, PDE-4 Inhibitors, Combination Therapies, Others); By Route of Administration (Inhalation, Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market is projected to grow at a steady CAGR of 6.1%, with an estimated value of USD 20.1 billion in 2024 and a fore... Read More

Published Date: DEC-2025 | No Of Pages:170 | $ 4485

Chronic Lymphocytic Leukemia Market By Therapy Type (Chemo-Immunotherapy, BTK Inhibitors, BCL2 Inhibitors, Others); By Diagnostics (MRD Assays, Cytogenetic Testing, Flow Cytometry, Others); By End User (Hospitals, Specialist Clinics, Outpatient Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Chronic Lymphocytic Leukemia Market is set to rise at a CAGR of 6.1%, increasing from 10.6 billion US dollars in 2024 to approximately 15.1 billion US dollars by 2... Read More

Published Date: DEC-2025 | No Of Pages:177 | $ 4485

Chronic Inducible Urticaria Treatment Market By Drug Class (Antihistamines, Leukotriene Receptor Antagonists, Biologics, Immunosuppressants); By Route of Administration (Oral, Subcutaneous, Others); By Distribution Channel (Hospital Pharmacies, Specialty Clinics, Retail & Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Chronic Inducible Urticaria Treatment Market is projected to rise from $1.3 billion in 2024 to $2.1 billion by 2030, registering a CAGR of 8.2%, driven by... Read More

Published Date: DEC-2025 | No Of Pages:166 | $ 4485

Chondrosarcoma Market By Type (Conventional, Dedifferentiated, Mesenchymal, Clear Cell); By Treatment Modality (Surgery, Radiation Therapy, Targeted Therapy, Immunotherapy); By End User (Academic Hospitals, Orthopedic Oncology Centers, Community Hospitals, Diagnostic Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chondrosarcoma Market is projected to grow from USD 1.2 billion in 2024 to nearly USD 1.80 billion by 2030, reflecting a CAGR of 7.3 %, driven by ... Read More

Published Date: DEC-2025 | No Of Pages:169 | $ 4485

Chemotherapy-Induced Diarrhea Treatment Market By Treatment Type (Anti-Diarrheal Agents, Oral Rehydration Solutions, Probiotics, Biologics); By Chemotherapy Regimen (Fluoropyrimidines, Irinotecan, Combination Therapies, Others); By End User (Hospitals & Oncology Centers, Outpatient Clinics & Homecare, Pharmacies & Retail); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chemotherapy-Induced Diarrhea Treatment Market is projected to witness a robust CAGR of 6.8%, valued at USD 1.2 billion in 2024Read More

Published Date: DEC-2025 | No Of Pages:160 | $ 4485

Chemotherapy Induced Peripheral Neuropathy Treatment Market By Drug Class (Antidepressants, Anticonvulsants, Topical Agents, Opioids, Neuroprotective Agents); By Mechanism of Action (Pain Modulation, Neuroprotection, Nerve Regeneration); By Route of Administration (Oral, Injectable, Transdermal); By Geography, Segment Revenue Estimation, Forecast, 2025–2030.

Introduction And Strategic Context

The Global Chemotherapy Induced Peripheral Neuropathy ( CIPN ) Treatment Market is projected to grow at a CAGR of 7.3 %, reaching a... Read More

Published Date: DEC-2025 | No Of Pages:200 | $ 4485

Checkpoint Inhibitor Refractory Cancer Market By Therapy Type (T-cell Engagers, Next-Generation Checkpoint Modulators, Cell Therapies, Small Molecule Immunomodulators, Combination Therapies); By Cancer Type (Melanoma, NSCLC, RCC, HNSCC, Others); By End User (Academic Cancer Centers, Specialty Oncology Clinics, General Hospitals, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Checkpoint Inhibitor Refractory Cancer Market will witness a robust CAGR of 9.6%, valued at USD 8.3 billion in 2024, and expected to reach around USD 14.4 billion ... Read More

Published Date: DEC-2025 | No Of Pages:171 | $ 4485

Cereblon E3 Ligase Modulators Market By Product Type (First-Generation IMiDs, Next-Generation Protein Degraders); By Indication (Hematologic Malignancies, Solid Tumors, Autoimmune Disorders); By End User (Hospital Oncology Departments, Specialty Cancer Centers, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cereblon E3 Ligase Modulators Market is projected to expand at a strong CAGR of 12.5%, rising from USD 2.1 billion in 2024 to USD 4.1 billion by 2030, fue... Read More

Published Date: DEC-2025 | No Of Pages:183 | $ 4485

CEACAM5 Drugs Market By Drug Type (Monoclonal Antibodies, Antibody-Drug Conjugates, CAR-T Therapies, Bispecific Antibodies); By Indication (Colorectal Cancer, Pancreatic Cancer, Non-Small Cell Lung Cancer, Other Solid Tumors); By Route of Administration (Intravenous, Subcutaneous); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CEACAM5 Drugs Market will witness a robust CAGR of 8.1%, valued at USD 2.1 billion in 2024, expected to appreciate and reach USD ... Read More

Published Date: DEC-2025 | No Of Pages:156 | $ 4485

CD38 Monoclonal Antibody Drugs Market By Therapy Type (Monotherapy, Combination Therapy); By Indication (Multiple Myeloma, Chronic Lymphocytic Leukemia, Autoimmune Disorders, Other Hematologic Malignancies); By Distribution Channel (Hospital Pharmacies, Community Oncology Clinics, Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD38 Monoclonal Antibody Drugs Market is projected to expand steadily between 2024 and 2030 , with an estimated value of USD 8.1 billion in 2024 and likel... Read More

Published Date: DEC-2025 | No Of Pages:200 | $ 4485

Catheter Related Bloodstream Infection Market By Product Type (Antimicrobial Catheters, CHG Dressings, Needleless Connectors, Catheter Lock Solutions); By Pathogen Type (Gram-Positive Bacteria, Gram-Negative Bacteria, Fungal Pathogens); By End User (Hospitals, Dialysis Clinics, Infusion Centers, Home Healthcare Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Catheter-Related Bloodstream Infection (CRBSI) Market is projected to grow at a steady CAGR of 6.5%, reaching USD 2.35 billion by 2030 from USD 1.6 billion in 2024... Read More

Published Date: DEC-2025 | No Of Pages:179 | $ 4485

Cardiac Amyloidosis Market By Product Type (Transthyretin Stabilizers, RNA Interference Therapies, Antisense Oligonucleotides, Monoclonal Antibodies, Diagnostics); By Application (Transthyretin Amyloidosis [Hereditary, Wild-type], Light Chain Amyloidosis); By End User (Hospitals, Specialty Cardiac Centers, Diagnostic Laboratories, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cardiac Amyloidosis Market will grow at a CAGR of 10.8% , valued at USD 4.2 billion in 2024 , and projected to reach USD 7.8 billion by 2030 , according t... Read More

Published Date: DEC-2025 | No Of Pages:180 | $ 4485

Cancer Tubulin Inhibitors Market By Drug Class (Vinca Alkaloids, Taxanes, Colchicine Site Binders, Synthetic Analogs); By Indication (Breast Cancer, Lung Cancer, Ovarian Cancer, Lymphomas, Leukemias, Rare Malignancies); By Route of Administration (Intravenous, Oral, Long-acting Injectable); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cancer Tubulin Inhibitors Market is set to grow at a robust CAGR of 6.8% , valued at USD 2.1 billion in 2024 , and projected to reach USD 3.1 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:186 | $ 4485

Cancer CDK Inhibitors Market By Drug Type (CDK4/6 Inhibitors, CDK7 Inhibitors, CDK9 Inhibitors, Multi-Target CDK Inhibitors); By Indication (Breast Cancer, Lung Cancer, Ovarian Cancer, Hematologic Malignancies, Others); By Route of Administration (Oral, Intravenous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cancer CDK Inhibitors Market is projected to expand at a robust CAGR of 9.5% , valued at USD 8.2 billion in 2024 and expected to reach around USD 14.2 billion by 2... Read More

Published Date: DEC-2025 | No Of Pages:187 | $ 4485

Cancer Anorexia Market By Product Type (Appetite Stimulants, Corticosteroids, Progestogens, Cannabinoids, Nutraceuticals, Biologics/Peptides); By Route of Administration (Oral, Injectable, Transdermal, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cancer Anorexia Market is expected to grow at a CAGR of 6.8% , valued at USD 2.9 billion in 2024 , and projected to reach USD 4.3 billion by 2030 , accord... Read More

Published Date: DEC-2025 | No Of Pages:185 | $ 4485

Cancer Angiogenesis Inhibitors Market By Drug Type (Monoclonal Antibodies, Tyrosine Kinase Inhibitors, Others); By Cancer Type (Colorectal, Lung, Renal, Hepatocellular, Breast, Others); By Route of Administration (Intravenous, Oral); By End User (Hospitals, Oncology Clinics, Academic Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cancer Angiogenesis Inhibitors Market will witness an estimated CAGR of 8.1% , valued at USD 15.7 billion in 2024 , and is expected to reach around USD 25.1 billio... Read More

Published Date: DEC-2025 | No Of Pages:169 | $ 4485

Bullous Pemphigoid Market By Drug Class (Corticosteroids, Immunosuppressants, Antibiotics, Biologics); By Route of Administration (Oral, Topical, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bullous Pemphigoid Market is forecast to grow at a CAGR of 6.1%, valued at USD 1.7 billion in 2024 and reaching USD 2.6 billion by 2030, driven by advance... Read More

Published Date: DEC-2025 | No Of Pages:155 | $ 4485

Bullous Keratopathy Market By Treatment Type (Corneal Transplantation [DMEK, DSAEK, Penetrating Keratoplasty], Pharmacological Therapy, Artificial Corneas, Supportive & Symptomatic Treatment); By Cause (Post-Cataract Surgery, Fuchs’ Dystrophy, Trauma, Infection, Congenital Disorders); By End User (Specialty Eye Hospitals, General Hospitals, ASCs, Academic/Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bullous Keratopathy Market is projected to grow steadily from USD 1.12 billion in 2024 to reach around USD 1.61 billion by 2030 , reflecting a CAG... Read More

Published Date: DEC-2025 | No Of Pages:157 | $ 4485

BTK Inhibitors Market By Type (Covalent BTK Inhibitors, Reversible BTK Inhibitors); By Application (Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Waldenström’s Macroglobulinemia, Rheumatoid Arthritis, Lupus, Multiple Sclerosis); By End User (Hospitals, Specialty Clinics, Research Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global BTK Inhibitors Market will register a strong CAGR of 11.9% , rising from $8.7 billion in 2024 to an estimated $17.2 billion by 20... Read More

Published Date: DEC-2025 | No Of Pages:200 | $ 4485

Bronchopulmonary Dysplasia Treatment Market By Treatment Type (Corticosteroids, Surfactants, Diuretics, Bronchodilators, Pulmonary Vasodilators); By Route of Administration (Intravenous, Inhalation, Oral, Intratracheal); By End User (NICUs, Pediatric Hospitals, Outpatient Pediatric Clinics, Community Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bronchopulmonary Dysplasia (BPD) Treatment Market is projected to expand steadily between 2024 and 2030, supported by rising preterm birth rates and advances in neonatal intensive care. Ba... Read More

Published Date: DEC-2025 | No Of Pages:195 | $ 4485

BRCA Mutations Treatment Market By Treatment Type (PARP Inhibitors, Hormonal Therapy, Chemotherapy, Targeted Combinations); By Cancer Type (Breast Cancer, Ovarian Cancer, Prostate Cancer, Pancreatic and Others); By End User (Hospitals and Cancer Centers, Specialty Oncology Clinics, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global BRCA Mutations Treatment Market is projected to reach a value of $5.8 billion in 2024 , with expectations to surpass $10.2 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:192 | $ 4485

Bone Metastasis Market By Treatment Type (Pharmaceuticals [Bisphosphonates, RANKL Inhibitors, Radiopharmaceuticals], Radiation Therapy, Surgical Interventions, Supportive Care); By Cancer Type (Breast Cancer, Prostate Cancer, Lung Cancer, Kidney Cancer, Thyroid & Others); By End User (Hospitals & Cancer Centers, Community Oncology Clinics, Specialty Orthopedic Centers, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bone Metastasis Market is expected to witness sustained growth, reaching USD 18.7 billion in 2024 and anticipated to cross USD 27.9 billion by 2030, reflecting a C... Read More

Published Date: DEC-2025 | No Of Pages:180 | $ 4485

Blepharitis Market By Type of Blepharitis(Anterior Blepharitis, Posterior Blepharitis, Mixed); By Treatment Type (Lid Hygiene Products, Prescription Pharmaceuticals, In-Office Procedures, Device-Based Home Therapies); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Blepharitis Market is projected to expand steadily between 2024 and 2030, growing at an CAGR of 5.8%, reaching approximately USD 1.9 billion in 2024 and estimated to cross... Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

Biliary Atresia Market By Treatment Type (Surgical Interventions, Liver Transplantation, Pharmacological Therapies); By Diagnosis Stage (Early Diagnosis, Delayed Diagnosis); By End User (Tertiary Pediatric Hospitals, Specialty Liver Transplant Units, General Hospitals with Pediatric Units); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Biliary Atresia Market is projected to expand steadily between 2024 and 2030, driven by rising awareness of neonatal liver disorders, earlier diagnostic interventions, and ongoing advances... Read More

Published Date: DEC-2025 | No Of Pages:197 | $ 4485

Beta Thalassemia Market By Therapy Type (Blood Transfusions, Iron Chelation Therapy, Gene Therapy & Gene Editing, Bone Marrow/Stem Cell Transplantation); By Route of Administration (Intravenous, Oral); By End User (Hospitals & Hematology Centers, Specialty Clinics, Retail & Online Pharmacies, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Beta Thalassemia Market is projected to expand steadily between 2024 and 2030, valued at USD 1.9 billion in 2024 and expected to reach USD 3.1 billion by 2030, reflecting ... Read More

Published Date: DEC-2025 | No Of Pages:161 | $ 4485

Benign Prostatic Hyperplasia Treatment Market By Therapy Type (Pharmacological, Minimally Invasive Surgical Therapies, Surgical Procedures); By Procedure Setting (Hospitals, Ambulatory Surgical Centers, Urology Clinics); By End User (Hospitals & Teaching Institutions, Specialty Urology Centers, Retail & Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Benign Prostatic Hyperplasia Treatment Market is expected to expand at a 6.9% CAGR, rising from $10.8 billion in 2024 to $16.1 billion by 2030, supported ... Read More

Published Date: DEC-2025 | No Of Pages:153 | $ 4485

AXL Receptor Tyrosine Kinase Inhibitors Market By Molecule Type (Small Molecule Inhibitors, Monoclonal Antibodies, Antibody-Drug Conjugates); By Application (Oncology, Fibrosis, Inflammatory Diseases); By Route of Administration (Oral, Intravenous); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global AXL Receptor Tyrosine Kinase (RTK) Inhibitors Market is anticipated to grow steadily between 2024 and 2030, with analysts estimating a ma... Read More

Published Date: DEC-2025 | No Of Pages:165 | $ 4485

Axial Spondyloarthritis Market By Drug Type (Biologics, csDMARDs, tsDMARDs); By Disease Type (Radiographic AxSpA, Non-Radiographic AxSpA); By End User (Hospitals, Specialty Rheumatology Clinics, Ambulatory Care Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Axial Spondyloarthritis Market will experience consistent growth at a CAGR of 7.4 %, increasing from USD 5.2 billion in 2024 to USD 7.98 billion by 2030, ... Read More

Published Date: DEC-2025 | No Of Pages:162 | $ 4485

Trace Oxygen Analyzer Market By Product Type (Portable, Benchtop, In-line/Process); By Technology (Electrochemical, Zirconia, Paramagnetic, Laser); By Application (Industrial, Medical, Laboratory, Semiconductor, Food & Beverage, Power Generation); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Trace Oxygen Analyzer Market is projected to expand at an estimated CAGR of 5.9%, valued at roughly $638 million in 2024 and expected to surpass $900 million by 20... Read More

Published Date: DEC-2025 | No Of Pages:160 | $ 4485

PDGFR Inhibitors Market By Drug Type (Monotherapy Inhibitors, Multi-Kinase Inhibitors); By Indication (Gastrointestinal Stromal Tumors, Glioblastoma, Pulmonary Fibrosis, Other Rare Disorders); By Route of Administration (Oral, Intravenous); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global PDGFR Inhibitors Market is projected to expand at a healthy pace between 2024 and 2030, with an estimated valuation of USD 3.1 billion in 2024 and expecte... Read More

Published Date: DEC-2025 | No Of Pages:191 | $ 4485

Trodelvy Market By Indication (Triple-Negative Breast Cancer, HR+/HER2- Breast Cancer, Urothelial Carcinoma, Non-Small Cell Lung Cancer, Others); By Line of Therapy (Second-Line, Third-Line and Beyond, Maintenance); By Distribution Channel (Hospital Pharmacies, Oncology Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Trodelvy Market will experience a strong growth trajectory between 2024 and 2030, rising from an estimated USD 1.62 billion in 2024 to nearly USD ... Read More

Published Date: DEC-2025 | No Of Pages:193 | $ 4485

Bcr Abl Tyrosine Kinase Inhibitor Drug Market By Drug Generation (First-Generation, Second-Generation, Third-Generation/Mutation-Specific); By Indication (Chronic Myeloid Leukemia, Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia, Others); By Route of Administration (Oral, Others); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bcr Abl Tyrosine Kinase Inhibitor Drug Market is set to grow at an CAGR of 6.8%, valued at USD 7.1 billion in 2024, and ... Read More

Published Date: DEC-2025 | No Of Pages:152 | $ 4485

PIM Kinase Targeted Therapies Market By Drug Type (Selective PIM Kinase Inhibitors, Dual/Multi-Target Kinase Inhibitors); By Cancer Type (Hematologic Malignancies, Solid Tumors); By Line of Therapy (First-Line, Second-Line and Beyond); By Route of Administration (Oral); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global PIM Kinase Targeted Therapies Market is projected to witness strong expansion between 2024 and 2030, with an inferred CAGR of 10.1%. The market is valued at approximately ... Read More

Published Date: DEC-2025 | No Of Pages:196 | $ 4485

mRNA Cancer Vaccines Market By Cancer Type (Melanoma, Lung, Pancreatic, Colorectal, Breast, Prostate); By Vaccine Type (Personalized mRNA Vaccines, Off-the-Shelf Vaccines); By Delivery Mechanism (Lipid Nanoparticles, Polymer-Based Carriers, Exosomes); By End User (Academic & Research Institutes, Specialty Oncology Clinics, General Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global mRNA Cancer Vaccines Market is set for transformative growth between 2024 and 2030, valued at USD 1.8 billion in 2024 and projected to reach nearly USD 7.3 billion by 2030... Read More

Published Date: DEC-2025 | No Of Pages:166 | $ 4485

MEK Inhibitors Market By Molecule Type (Trametinib, Cobimetinib, Binimetinib, Selumetinib, Others); By Application (Melanoma, Non-Small Cell Lung Cancer, Colorectal Cancer, Neurofibromatosis Type 1, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online & Specialty Distributors); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global MEK Inhibitors Market is projected to expand steadily between 2024 and 2030, supported by deeper adoption of targeted oncology therapies and ongoing approvals of next-gene... Read More

Published Date: DEC-2025 | No Of Pages:164 | $ 4485

Lupus Nephritis Treatment Market By Drug Class (Immunosuppressants, Biologics, Corticosteroids, ACE Inhibitors & ARBs, Antimalarials); By Route of Administration (Oral, Intravenous, Subcutaneous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Lupus Nephritis Treatment Market is projected to grow at a CAGR of 10.4%, expanding from USD 1.6 billion in 2024 to approximately USD 2.9 billion ... Read More

Published Date: DEC-2025 | No Of Pages:165 | $ 4485

SYK Inhibitors Market By Molecule Type (Small Molecule, Biologic); By Indication (Hematological Malignancies, Autoimmune Diseases, Inflammatory Disorders); By Route of Administration (Oral, Parenteral); By End User (Hospitals, Specialty Clinics, Pharmacies); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global SYK Inhibitors Market is expected to grow at a robust CAGR of 23.5%, estimated at $635 million in 2024 and projected to reach nearly Read More

Published Date: DEC-2025 | No Of Pages:170 | $ 4485

Insulin Biosimilar Market By Product Type (Basal, Bolus, Premixed); By Disease Type (Type 1 Diabetes, Type 2 Diabetes); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Insulin Biosimilar Market is projected to expand steadily between 2024 and 2030, growing at an estimated CAGR of 9.1%, with market value expected to reach USD 7.8 ... Read More

Published Date: DEC-2025 | No Of Pages:162 | $ 4485

TROP2 Antibody Market By Drug Type (Monoclonal Antibodies, Antibody-Drug Conjugates, Bispecific Antibodies); By Application (Breast Cancer, Non-Small Cell Lung Cancer, Urothelial Carcinoma, Others); By End User (Academic & Research Hospitals, Oncology Specialty Clinics, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global TROP2 Antibody Market will witness a robust CAGR of 20.6%, valued at USD 1.8 billion in 2024, expected to appreciate and reach US... Read More

Published Date: DEC-2025 | No Of Pages:171 | $ 4485

CD40 Targeted Therapies Market By Therapy Type (Monoclonal Antibodies, Fusion Proteins, Small Molecules); By Indication (Oncology, Autoimmune Diseases, Transplantation); By Route of Administration (Intravenous, Subcutaneous); By End User (Hospitals, Specialty Clinics, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD40 Targeted Therapies Market is projected to grow at a robust CAGR of 11.8%, reaching an estimated valuation of USD 3.9 billion by 2030... Read More

Published Date: DEC-2025 | No Of Pages:169 | $ 4485

Anaplastic Lymphoma Kinase (ALK) Inhibitors Market By Drug Generation (First-Generation, Second-Generation, Third-Generation); By Application (Non-Small Cell Lung Cancer, Anaplastic Large Cell Lymphoma, Pediatric & Rare Cancers); By End User (Cancer Specialty Hospitals, General Hospitals, Outpatient Oncology Clinics, Diagnostic Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Anaplastic Lymphoma Kinase (ALK) Inhibitors Market is positioned for steady expansion over the next several years, with a robust Read More

Published Date: DEC-2025 | No Of Pages:154 | $ 4485

KRAS Inhibitors Market By Mutation Type (KRAS G12C, KRAS G12D, Other Mutations); By Cancer Type (NSCLC, Colorectal Cancer, Pancreatic Cancer, Other Cancers); By Drug Type (Monotherapy, Combination Therapy); By Route of Administration (Oral, Parenteral); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global KRAS Inhibitors Market is projected to expand steadily over the next decade. Valued at roughly USD 2.1 billion in 2024, it is expected to surpass ... Read More

Published Date: DEC-2025 | No Of Pages:198 | $ 4485

Protein Misfolding & Aggregation Disorder Therapies (PMADT) Market By Target Protein (Amyloid-β, Tau, α-Synuclein, Huntingtin, TDP-43, Others); By Therapeutic Modality (Monoclonal Antibodies, RNA/Antisense Therapies, Small Molecule Modulators, Gene Therapy & Advanced Platforms); By Indication (Alzheimer’s, Parkinson’s, ALS, Huntington’s, Rare Proteinopathies); By Line of Therapy; By Region, Segment Revenue Estimation, Forecast, 2025–2035

1. Introduction and Strategic Context

The global Protein Misfolding & Aggregation Disorder Therapies (PMADT) Market is projected to reach USD 1.7 billion by 2035, up from around USD 0.6 billion in 2025, growing at... Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

PLK Targeted Therapies Market By Drug Type (PLK1 Inhibitors, Multi-Kinase Inhibitors); By Cancer Indication (Acute Myeloid Leukemia, Prostate Cancer, Ovarian Cancer, Breast Cancer, NSCLC); By Line of Therapy (First-Line, Second-Line, Maintenance/Combo Therapy); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global PLK Targeted Therapies Market is expanding at a robust 8.5% CAGR, rising from USD 1.1 billion in 2024 to nearly USD 1.9 billion by 2030, driven by PLK1 in... Read More

Published Date: DEC-2025 | No Of Pages:167 | $ 4485

Gamma Delta T Cell Cancer Therapy Market By Therapy Type (Allogeneic, Autologous); By Cancer Indication (Hematologic Malignancies, Solid Tumors); By Delivery Method (Non-Engineered, Genetically Modified); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Gamma Delta T Cell Cancer Therapy Market is projected to grow at a robust 32.6% CAGR, rising from USD 318 million in 2024 to approximately USD 2.1 billion by 2030<... Read More

Published Date: DEC-2025 | No Of Pages:163 | $ 4485

Cancer Photodynamic Therapy (PDT) Market By Product Type (Photosensitizing Agents, Light Delivery Systems); By Cancer Application (Lung Cancer, Esophageal Cancer, Bladder Cancer, Head & Neck Cancer, Skin Cancer, Others); By End User (Hospitals, Cancer Specialty Centers, Ambulatory Surgical Centers, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cancer Photodynamic Therapy (PDT) Market is projected to grow at a 8.9% CAGR, rising from USD 1.5 billion in 2024 to USD 2.7 billion by 2030, driven by ad... Read More

Published Date: DEC-2025 | No Of Pages:180 | $ 4485

CD5 Targeting Therapies Market By Therapy Type (Monoclonal Antibodies, Bispecific Antibodies, Antibody-Drug Conjugates, Small Molecule Inhibitors); By Indication (Hematologic Malignancies, Autoimmune Disorders, Graft-Versus-Host Disease); By End User (Hospitals and Cancer Centers, Academic and Research Institutes, Specialty Clinics, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD5 Targeting Therapies Market is projected to grow at a 10.4% CAGR, rising from USD 1.8 billion in 2024 to USD 3.6 billion by 2030, driven by advances in... Read More

Published Date: DEC-2025 | No Of Pages:199 | $ 4485

Trigeminal Neuralgia Treatment Market By Treatment Type (Pharmacological Therapy, Surgical Procedures, Non-Invasive Therapies); By Drug Class (Anticonvulsants, Muscle Relaxants, Antidepressants, Others); By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Trigeminal Neuralgia Treatment Market is valued at USD 675 million in 2024 and projected to reach USD 1.02 billion by 2030, expanding at a 7.1% CAGR, driv... Read More

Published Date: DEC-2025 | No Of Pages:185 | $ 4485

DLL3 Targeted Therapies Market By Therapy Type (Antibody-Drug Conjugates, Bispecific Antibodies, Small Molecules, Cell Therapies); By Indication (Small Cell Lung Cancer, Large Cell Neuroendocrine Carcinoma, Other DLL3-Positive Tumors); By Route of Administration (Intravenous, Subcutaneous); By End User (Hospitals, Cancer Specialty Centers, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global DLL3 Targeted Therapies Market is valued at USD 472.5 million in 2024 and projected to reach USD 1.34 billion by 2030, growing at a robust 18.9% CAGR, dri... Read More

Published Date: DEC-2025 | No Of Pages:168 | $ 4485

Selective Estrogen Receptor Degrader (SERD) Market By Product Type (Injectable SERDs, Oral SERDs); By Route of Administration (Intramuscular, Oral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Selective Estrogen Receptor Degrader (SERD) Market is projected to grow at a CAGR of 8.9%, rising from USD 2.4 billion in 2024 to USD 4.0 billion by 2030,... Read More

Published Date: DEC-2025 | No Of Pages:164 | $ 4485

CDC7 Kinase Inhibitors Drugs Market By Drug Type (Small Molecule Inhibitors, Combination Therapies); By Cancer Indication (Hematologic Malignancies, Solid Tumors); By Route of Administration (Oral, Intravenous); By End User (Academic Hospitals, Cancer Centers, Community Oncology Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CDC7 Kinase Inhibitors Drugs Market is projected to grow at a robust 18.2% CAGR, rising from $487 million in 2024 to $1.33 billion by 2030, driven by adva... Read More

Published Date: DEC-2025 | No Of Pages:157 | $ 4485

PROTAC Inhibitors Market By Type (Bifunctional PROTACs, Molecular Glue Degraders); By Therapeutic Area (Oncology, Neurodegenerative Diseases, Autoimmune Disorders); By End User (Academic & Research Institutes, Specialty Oncology Centers, CROs, Pharma Companies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global PROTAC Inhibitors Market is projected to expand at a robust 28.7% CAGR, rising from USD 417 million in 2024 to over USD 1.9 billion by 2030, driven by adv... Read More

Published Date: DEC-2025 | No Of Pages:169 | $ 4485

CD19 Antibody Market By Antibody Type (Monoclonal Antibodies, Bispecific Antibodies, Antibody-Drug Conjugates); By Application (Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Autoimmune Disorders, Others); By End User (Hospitals, Specialty Cancer Centers, Community Hospitals & Clinics, Outpatient Infusion Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD19 Antibody Market is projected to grow at a robust 14.8% CAGR, expanding from USD 3.1 billion in 2024 to approximately USD 7.1 billion by 2030, driven ... Read More

Published Date: DEC-2025 | No Of Pages:174 | $ 4485

STAT3 Inhibitors Market By Drug Type (Small Molecule Inhibitors, Antisense Oligonucleotides, Peptides, Protein Degraders); By Route of Administration (Oral, Injectable, Localized/Intratumoral); By Application (Oncology, Inflammatory Diseases, Fibrosis, Autoimmune Disorders); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global STAT3 Inhibitors Market is projected to grow at a 6.5% CAGR from USD 410.0 million in 2024 to over USD 600.0 million by 2030, driven by advances in target... Read More

Published Date: DEC-2025 | No Of Pages:174 | $ 4485

CD123 Targeted Therapy Market By Therapy Type (Antibody-Drug Conjugates, Monoclonal Antibodies, Bispecific Antibodies, CAR-T Therapies); By Application (Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Neoplasm, Myelodysplastic Syndromes, Others); By End User (Academic & Research Hospitals, Cancer Specialty Centers, Community Hospitals & Clinics, CROs & Trial Sites); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD123 Targeted Therapy Market is projected to grow from USD 2.1 billion in 2024 to USD 5.3 billion by 2030, registering a strong 16.7% CAGR, driven b... Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

CD276 Antibody Market By Type (Monoclonal Antibodies, Antibody-Drug Conjugates, Bispecific Antibodies); By Application (Oncology, Immuno-Oncology Research); By End User (Biopharmaceutical Companies, Academic & Research Institutions, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD276 Antibody Market is valued at USD 450 million in 2024 and is projected to reach USD 1.1 billion by 2030, expanding at a strong 15.8% CAGR, driven by ... Read More

Published Date: DEC-2025 | No Of Pages:173 | $ 4485

Targeted Alpha Therapy Market By Isotope Type (Actinium-225, Thorium-227, Bismuth-213, Others); By Therapeutic Area (Prostate Cancer, Leukemia, Glioblastoma, Neuroendocrine Tumors, Others); By End User (Academic Cancer Centers, Oncology Hospitals, Radiopharmacies & Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Targeted Alpha Therapy Market is projected to grow at a strong 20.8% CAGR, increasing from USD 1.34 billion in 2024 to USD 4.12 billion by 2030, driven by... Read More

Published Date: DEC-2025 | No Of Pages:172 | $ 4485

mTOR Inhibitors Market By Product Type (Rapamycin Derivatives [Sirolimus, Everolimus, Temsirolimus], Next-Generation mTOR Inhibitors); By Therapeutic Indication (Oncology, Immunosuppressive Therapy, Rare Genetic Disorders); By Route of Administration (Oral, Intravenous); By End User (Hospitals, Specialty Cancer Centers, Transplant Clinics, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global mTOR Inhibitors Market is projected to grow at a robust 8.1% CAGR, rising from USD 7.2 billion in 2024 to USD 11.5 billion by 2030, driven by expanding on... Read More

Published Date: DEC-2025 | No Of Pages:170 | $ 4485

Bicycle Toxin Conjugates Market By Product Type (Proprietary BTCs, Platform-Based BTCs, Next-Gen Conjugates); By Application (Oncology, Rare Diseases, Infectious Diseases); By End User (Academic Medical Centers, Cancer Institutes, Specialized Hospitals, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bicycle Toxin Conjugates Market is projected to grow at a robust 8.9% CAGR, expanding from $2.1 billion in 2024 to $3.6 billion by 2030, driven by advance... Read More

Published Date: DEC-2025 | No Of Pages:170 | $ 4485

CD137 Antibody Market By Type (Monoclonal Antibodies, Bispecific Antibodies, Fc-Engineered Variants); By Application (Solid Tumors, Hematologic Malignancies, Combination Immunotherapy); By Development Stage (Preclinical, Phase I, Phase II, Phase III); By End User (Academic Cancer Centers, Biopharma Companies, CROs, Specialty Oncology Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD137 Antibody Market is valued at USD 782 million in 2024 and is projected to reach USD 1.43 billion by 2030, expanding at a strong 10.6% CAGR, driven by... Read More

Published Date: DEC-2025 | No Of Pages:178 | $ 4485

C5 Complement Inhibitors Drug Market By Drug Type (Monoclonal Antibodies, RNAi-based Therapies, Small Molecules & Novel Modalities); By Route of Administration (Intravenous, Subcutaneous); By Indication (Paroxysmal Nocturnal Hemoglobinuria, Atypical Hemolytic Uremic Syndrome, Generalized Myasthenia Gravis, Neurological & Renal Autoimmune Disorders); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global C5 Complement Inhibitors Drug Market is valued at USD 9.8 billion in 2024 and projected to reach USD 16.7 billion by 2030, expanding at a strong 9.3% CAGR... Read More

Published Date: DEC-2025 | No Of Pages:160 | $ 4485

CD3 Antibodies Market By Product Type (Monospecific CD3 Antibodies, Bispecific and Multispecific CD3 Antibodies); By Application (Oncology, Autoimmune Diseases, Transplantation, Others); By End User (Academic Hospitals, Specialty Clinics, Community Hospitals, CROs); By Route of Administration (Intravenous, Subcutaneous, Other Routes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD3 Antibodies Market is projected to grow from USD 2.7 billion in 2024 to nearly USD 5.0 billion by 2030, expanding at a strong 10.8% CAGR, driven by adv... Read More

Published Date: DEC-2025 | No Of Pages:160 | $ 4485

GPRC5D Targeting Drugs Market By Therapy Type (Bispecific Antibodies, CAR-T Cell Therapies, Antibody-Drug Conjugates); By Indication (Relapsed/Refractory Multiple Myeloma, High-Risk/Smoldering Myeloma, Solid Tumors); By Route of Administration (Intravenous, Subcutaneous); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global GPRC5D Targeting Drugs Market is projected to witness a robust CAGR of 36.5%, with an estimated valuation of USD 487 million in 2024, expected to surpass USD 3.2 b... Read More

Published Date: DEC-2025 | No Of Pages:162 | $ 4485

CD70 Targeting Therapies Market By Therapy Type (Monoclonal Antibodies, Antibody-Drug Conjugates, CAR-T Cell Therapy, Bispecific Antibodies); By Indication (Renal Cell Carcinoma, Lymphomas, Acute Myeloid Leukemia, Others); By Route of Administration (Intravenous, Subcutaneous); By End User (Hospitals, Specialty Clinics, Academic & Research Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD70 Targeting Therapies Market is projected to grow at a strong CAGR of 17.4%, rising from USD 1.2 billion in 2024 to USD 3.1 billion by 2030, fueled by ... Read More

Published Date: DEC-2025 | No Of Pages:200 | $ 4485

TRK Inhibitors Market By Drug Type (First-generation TRK inhibitors, Next-generation TRK inhibitors); By Cancer Indication (Non-small cell lung cancer, Soft tissue sarcoma, Thyroid cancer, Pediatric tumors, Others); By End User (Oncology centers, Academic hospitals, Community hospitals, Diagnostic labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global TRK Inhibitors Market is projected to grow at a robust 12.6% CAGR, rising from USD 3.1 billion in 2024 to USD 6.4 billion by 2030, driven by expanding NTR... Read More

Published Date: DEC-2025 | No Of Pages:152 | $ 4485

Dysmenorrhea Treatment Market By Treatment Type (NSAIDs, Hormonal Therapy, Complementary Therapies, Surgical Intervention); By Route of Administration (Oral, Injectable, Transdermal, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Dysmenorrhea Treatment Market is projected to grow from USD 6.8 billion in 2024 to USD 10.1 billion by 2030, expanding at a 6.8% CAGR, driven by rising diagnosis rates, ho... Read More

Published Date: DEC-2025 | No Of Pages:167 | $ 4485

Fecal Microbiota Transplants (FMT) Market By Product Type (Traditional Fecal Suspensions, Processed Microbiota Formulations); By Route of Administration (Colonoscopy, Enema, Nasogastric/Nasoduodenal Tube, Oral Capsules); By End User (Hospitals, Specialty Clinics, Research Institutes, Stool Banks); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Fecal Microbiota Transplants (FMT) Market is poised to witness a robust CAGR of approximately 1... Read More

Published Date: DEC-2025 | No Of Pages:191 | $ 4485

ATR Protein Inhibitors Market By Drug Type (Oral, Intravenous); By Application (Solid Tumors [Ovarian, Lung, Breast, Pancreatic], Hematologic Malignancies); By Combination Regimen (Monotherapy, Combination Therapy [PARP Inhibitors, Immunotherapy]); By End User (Academic Hospitals, Community Oncology Centers, Specialty Clinics); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global ATR Protein Inhibitors Market is projected to grow at a robust 14.8% CAGR, rising from $685 million in 2024 to $1.7 billion by 2030, driven by advances in... Read More

Published Date: DEC-2025 | No Of Pages:173 | $ 4485

Flow Imaging Microscopy Market By Instrument Type (Benchtop Systems, Portable Systems); By Application (Biopharmaceutical Analysis, Nanoparticle Characterization, Environmental Monitoring, Food & Beverage Testing); By End User (Biotech & Pharma Companies, Academic & Research Institutes, Environmental Testing Labs, Food & Beverage Manufacturers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Flow Imaging Microscopy Market is projected to grow from USD 210 million in 2024 to USD 327 million by 2030 at a 7.6% CAGR, driven by rising demand in biopharmaceutical quality control, na... Read More

Published Date: DEC-2025 | No Of Pages:175 | $ 4485

RET Inhibitors Drug Market By Drug Type (Selective RET Inhibitors, Multikinase Inhibitors); By Indication (NSCLC, Thyroid Cancer, Other RET-Altered Tumors); By Route of Administration (Oral, Intravenous); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global RET Inhibitors Drug Market will witness a robust CAGR of 12.3%, valued at an estimated USD 3.2 billion in 2024, and projected to reach ar... Read More

Published Date: DEC-2025 | No Of Pages:185 | $ 4485

B-Cell Maturation Antigen (BCMA) Targeted Therapies Market By Therapy Type (CAR-T Cell Therapy, Bispecific Antibodies, Antibody-Drug Conjugates); By Indication (Multiple Myeloma, Lymphoma, Other B-cell Malignancies); By Line of Therapy (Third-line and Beyond, Earlier-line Settings); By End User (Academic Hospitals, Community Oncology Centers, Specialty Infusion Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global B-Cell Maturation Antigen (BCMA) Targeted Therapies Market is projected to expand at a... Read More

Published Date: DEC-2025 | No Of Pages:182 | $ 4485

MCL1 Inhibitor Drugs Market By Drug Type (Small Molecule Inhibitors, Biologics/Peptide-Based Agents); By Indication (Hematologic Malignancies [AML, CLL, Multiple Myeloma], Solid Tumors [NSCLC, TNBC, Pancreatic Cancer]); By Route of Administration (Oral, Intravenous); By End User (Tertiary Cancer Centers, Oncology Networks, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global MCL1 Inhibitor Drugs Market will witness a robust CAGR of 13.4%, valued at USD 672 million in 2024, and is expected to reach around Read More

Published Date: DEC-2025 | No Of Pages:180 | $ 4485

Multispecific Antibodies Market By Technology Type (Bispecific Antibodies, Trispecific Antibodies, Other Multispecific Formats); By Therapeutic Application (Oncology, Autoimmune & Inflammatory Disorders, Infectious Diseases, Others); By End User (Hospitals & Cancer Centers, Specialty Clinics, Research & Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Multispecific Antibodies Market is gaining momentum, with the sector projected to expand steadily between 2024 and 2030. Based on inferred estimates, the market is valued ... Read More

Published Date: DEC-2025 | No Of Pages:180 | $ 4485

Autosomal Dominant Polycystic Kidney Disease Market By Drug Class (Vasopressin V2 Receptor Antagonists, Somatostatin Analogs, mTOR Inhibitors, Anti-Inflammatory & Antifibrotic Agents); By Diagnostic & Monitoring Tools (MRI/CT Imaging, Genetic Testing, Biomarker Platforms); By End User (Nephrology Clinics, Specialty Hospitals, Diagnostic/Imaging Centers, Digital Health & Home Monitoring Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Autosomal Dominant Polycystic Kidney Disease (ADPKD) Market is projected to grow from $2.7 billion in 2024 to $3.8 billion by 2030 at a 5.9% CAGR, driven ... Read More

Published Date: DEC-2025 | No Of Pages:188 | $ 4485

Autosomal Dominant Optic Atrophy Market By Treatment Type (Gene Therapy, Supportive & Neuroprotective Therapies); By Diagnosis Stage (Early-Stage Diagnosis, Late-Stage Diagnosis); By End User (Academic Hospitals, Ophthalmology Clinics, Genetic Testing Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Autosomal Dominant Optic Atrophy Market is estimated to reach around USD 143 million in 2024 and is projected to grow at a CAGR of 9.6% , ultimately surpassing USD... Read More

Published Date: DEC-2025 | No Of Pages:161 | $ 4485

Autoimmune Encephalitis Treatment Market By Treatment Type (Acute Immunotherapy, Maintenance Immunotherapy, Adjunctive Care); By Antibody Subtype (Anti-NMDA, LGI1, CASPR2, GABA, AMPA, Others); By End User (Tertiary Hospitals, General Hospitals, Neurology Clinics, Pediatric Centers, Infusion Facilities); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Autoimmune Encephalitis Treatment Market is projected to grow at a robust CAGR of 8.1% , with an estimated value of USD 3.2 billion in 2024 and expected to reach U... Read More

Published Date: DEC-2025 | No Of Pages:188 | $ 4485

Atypical Hemolytic Uremic Syndrome Market By Drug Class (C5 Inhibitors, C3 Inhibitors, MASP-2 Inhibitors, RNAi Therapies, Others); By Route of Administration (Intravenous, Subcutaneous, Oral); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Online Platforms); By End User (Hospitals, Specialty Clinics, Pediatric Centers, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Atypical Hemolytic Uremic Syndrome (Ahus) Market will witness a steady Compound Annual Growth Rate (CAGR) of 7.8... Read More

Published Date: DEC-2025 | No Of Pages:184 | $ 4485

Atrophic Vaginitis Treatment Market By Treatment Type (Hormonal [Estrogen Tablets, Creams, Rings, SERMs], Non-Hormonal [Moisturizers, Hyaluronic Acid, Laser & RF Devices]); By Route of Administration (Topical, Oral, Device-Based); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online & Telehealth Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Atrophic Vaginitis Treatment Market is projected to reach $3.1 billion by 2030 , up from $1.9 billion in 2024 , growing at a CAGR of 8.5% over the forecas... Read More

Published Date: DEC-2025 | No Of Pages:181 | $ 4485

Astrocytoma Market By Grade (Low-Grade [Grade I & II], High-Grade [Grade III & IV]); By Treatment (Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy); By End User (Hospitals, Oncology Centers, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Astrocytoma Market is projected to grow from USD 2.1 billion in 2024 to USD 3.0 billion by 2030 at a 5.8% CAGR, driven by advances in neurosurgery, molecu... Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

Aryl Hydrocarbon Receptor Market By Drug Type (AhR Agonists, AhR Antagonists, Natural Ligands, Synthetic Ligands); By Therapeutic Application (Oncology, Autoimmune Disorders, Gastrointestinal Disease, Neuroinflammation, Dermatology); By Mechanism of Action (Direct Modulators, Indirect Modulators); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Aryl Hydrocarbon Receptor (Ahr) Market is projected to grow at a steady CAGR of 6.1%, estimated to reach approximately USD 738.4 million by 2030Read More

Published Date: DEC-2025 | No Of Pages:156 | $ 4485

Aromatase Inhibitors Market By Drug Type (Anastrozole, Letrozole, Exemestane); By Application (Breast Cancer, Ovarian Cancer, Male Breast Cancer, Endometriosis, Fertility Treatment – PCOS); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Aromatase Inhibitors Market is projected to grow from USD 2.7 billion in 2024 to USD 3.8 billion by 2030 at a 5.8% CAGR, driven by sustained HR+ breast cancer treatment demand, long-term e... Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

Angiotensin-Converting Enzyme (ACE) Inhibitors Market By Product Type (Lisinopril, Enalapril, Ramipril, Captopril, Benazepril, Others); By Application (Hypertension, Heart Failure, Myocardial Infarction, Diabetic Nephropathy, CKD, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Angiotensin-Converting Enzyme Inhibitors Market is projected to expand at a CAGR of 5.8% , reaching nearly USD 8... Read More

Published Date: DEC-2025 | No Of Pages:186 | $ 4485

Angioimmunoblastic T-cell Lymphoma Market By Therapy Type (Chemotherapy Regimens, Targeted Therapies, Monoclonal Antibodies & Biologics, Stem Cell Transplant); By Line of Therapy (First-Line, Second-Line and Beyond); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Angioimmunoblastic T -Cell Lymphoma Market is projected to expand at a CAGR of 8.1% , moving from an es... Read More

Published Date: DEC-2025 | No Of Pages:163 | $ 4485

Aneurysmal Subarachnoid Hemorrhage Market By Treatment Type (Endovascular Coiling, Surgical Clipping, Pharmacologic Therapy); By Drug Class (Calcium Channel Blockers, Vasodilators, Endothelin Receptor Antagonists, Neuroprotective Agents); By End User (Tertiary Stroke Centers, General Hospitals, Academic Medical Centers, Ambulatory Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Aneurysmal Subarachnoid Hemorrhage Market is estimated to be worth USD 1.74 billion in 2024 , and it's projected to reach around Read More

Published Date: DEC-2025 | No Of Pages:156 | $ 4485

ANCA Associated Vasculitis Market By Disease Type (Granulomatosis with Polyangiitis, Microscopic Polyangiitis, Eosinophilic Granulomatosis with Polyangiitis); By Treatment Class (Corticosteroids, Immunosuppressants, Biologic Therapies, Plasma Exchange & Adjunct Therapies); By Route of Administration (Oral, IV, Subcutaneous); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global ANCA Associated Vasculitis (AAV) Market is forecast to expand steadily, with an inferred CAGR of 6.1% , valued at roughly USD 1.6 billion in 2024 and proj... Read More

Published Date: DEC-2025 | No Of Pages:189 | $ 4485

Alport Syndrome Market By Product Type (Pharmacological Therapies, Gene and Cell Therapies, Supportive Care); By Route of Administration (Oral, Intravenous, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Alport Syndrome Market is projected to grow from USD 412 million in 2024 to nearly USD 615 million by 2030 at a 6.8% CAGR, driven by advances in genetic t... Read More

Published Date: DEC-2025 | No Of Pages:188 | $ 4485

Alpha-synuclein Inhibitors Market By Drug Class (Small Molecules, Monoclonal Antibodies, Peptide Inhibitors); By Mechanism of Action (Aggregation Inhibitors, Misfolding Blockers, Clearance Enhancers); By Indication (Parkinson’s Disease, Multiple System Atrophy, Lewy Body Dementia); By Distribution Channel (Hospital Pharmacies, Specialty Clinics, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Alpha-Synuclein Inhibitors Market is projected to grow at a strong 21.8% CAGR, rising from USD 1.2 billion in 2024 to USD 3.9 billion by 2030, driven by a... Read More

Published Date: DEC-2025 | No Of Pages:154 | $ 4485

Alpha-1 Antitrypsin Deficiency Market By Therapy Type (Augmentation Therapy, Gene Therapy, Small Molecule Drugs); By Route of Administration (Intravenous, Inhalation, Subcutaneous); By Disease Manifestation (Pulmonary, Liver, Others); By End User (Hospitals, Specialty Clinics, Home Infusion Services, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Alpha-1 Antitrypsin Deficiency Market is projected to grow from USD 2.8 billion in 2024 to USD 4.1 billion by 2030 at a 6.3% CAGR, driven by augmentation ... Read More

Published Date: DEC-2025 | No Of Pages:179 | $ 4485

Alpha Thalassemia Treatment Market By Treatment Type (Blood Transfusions, Iron Chelation Therapy, Gene Therapy, HbF Inducers); By Disease Type (Alpha Thalassemia Trait, Hemoglobin H Disease, Hb Bart’s Hydrops Fetalis); By Route of Administration (Parenteral, Oral); By Distribution Channel (Hospital Pharmacies, Retail & Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Alpha Thalassemia Treatment Market is projected to grow at a 6.9% CAGR, rising from USD 536.4 million in 2024 to USD 802.7 million by 2030, driven by adva... Read More

Published Date: DEC-2025 | No Of Pages:200 | $ 4485

Alopecia Areata Market By Treatment Type (Topical Treatments, Oral/Systemic Treatments, Injectable Therapies, Biologics/Pipeline Drugs); By Patient Age Group (Pediatric, Adult); By End User (Hospitals and Specialty Clinics, Outpatient/Community Clinics, Telemedicine/Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Alopecia Areata Market is projected to grow at a robust 7.8% CAGR, rising from USD 3.2 billion in 2024 to nearly USD 5.0 billion by 2030, driven by r... Read More

Published Date: DEC-2025 | No Of Pages:185 | $ 4485